Loading clinical trials...
Loading clinical trials...
Phase II Study of Low-Dose Ibuprofen for Cognitive Problems in Patients With Cancer
Conditions
Interventions
Ibuprofen
Placebo
+1 more
Locations
169
United States
Providence Saint Joseph Medical Center/Disney Family Cancer Center
Burbank, California, United States
Beebe Medical Center
Lewes, Delaware, United States
Delaware Clinical and Laboratory Physicians PA
Newark, Delaware, United States
Helen F Graham Cancer Center
Newark, Delaware, United States
Medical Oncology Hematology Consultants PA
Newark, Delaware, United States
Regional Hematology and Oncology PA
Newark, Delaware, United States
Start Date
May 26, 2017
Primary Completion Date
March 30, 2022
Completion Date
June 1, 2022
Last Updated
September 25, 2023
NCT00026884
NCT07220668
NCT06154174
NCT04123314
NCT04585750
NCT06780917
Lead Sponsor
University of Rochester NCORP Research Base
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions